Design Therapeautics, Inc. Share Price Today: Live Updates & Key Insights
Design Therapeautics, Inc. share price today is $11.64, up 1.29%. The stock opened at $11.815 against the previous close of $11.63, with an intraday high of $12.08 and low of $11.41.
Design Therapeautics, Inc. Share Price Chart
Design Therapeautics, Inc.
Design Therapeautics, Inc. Share Price Performance
Design Therapeautics, Inc. Institutional Holdings
Design Therapeautics, Inc. Market Status
Design Therapeautics, Inc. Fundamentals
Market Cap 726.37 M
PB Ratio 3.377
PE Ratio 0.0
Enterprise Value 515.65 M
Total Assets 226.20 M
Volume 417084
Design Therapeautics, Inc. Company Financials
About Design Therapeautics, Inc. & investment objective
Company Information Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. The company was incorporated in 2017 and is headquartered in Carlsbad, California.
Organisation Biotechnology
Employees 54
Industry Biotechnology
CEO Mr. Pratik Shah Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Design Therapeautics, Inc. FAQs
What is the share price of Design Therapeautics, Inc. today?
The current share price of Design Therapeautics, Inc. is $11.64.
Can I buy Design Therapeautics, Inc. shares in India?
Yes, Indian investors can buy Design Therapeautics, Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Design Therapeautics, Inc. shares in India?
You can easily invest in Design Therapeautics, Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Design Therapeautics, Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Design Therapeautics, Inc..
Can I buy fractional shares of Design Therapeautics, Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Design Therapeautics, Inc.?
Design Therapeautics, Inc. has a market cap of $726.37 M.
In which sector does Design Therapeautics, Inc. belong?
Design Therapeautics, Inc. operates in the Biotechnology sector.
What documents are required to invest in Design Therapeautics, Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Design Therapeautics, Inc.?
The PE ratio of Design Therapeautics, Inc. is N/A and the PB ratio is 3.38.